ViAqua Therapeutics Overview

  • Founded
  • 2014

Founded
  • Status
  • Private

  • Employees
  • 12

Employees
  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $4.3M

  • Investors
  • 8

ViAqua Therapeutics General Information

Description

Developer of an orally administered particle-based platform designed to prevent diseases from developing viral epidemics in aquaculture. The company's platform utilizes a proprietary RNAi nanoparticle formulation that triggers a cellular reaction to disable the viral infection and delivers the coated nanoparticles via feed or immersion, enabling aquaculture industries to improve resistance against viral diseases that attack shrimp and other aquaculture species.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Aquaculture
Primary Office
  • Gutwirth Park
  • Technion City
  • Haifa 3200003
  • Israel
+972 000-000-0000

ViAqua Therapeutics Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ViAqua Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 09-Jun-2021 $4.3M 00.00 Completed Generating Revenue
3. Early Stage VC 18-Dec-2018 000 000 Completed Generating Revenue
2. Early Stage VC 04-Jul-2018 Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view ViAqua Therapeutics’s complete valuation and funding history, request access »

ViAqua Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of an orally administered particle-based platform designed to prevent diseases from developing viral epidemics
Biotechnology
Haifa, Israel
12 As of 2022
00.00
0000000000 0 00.00

000000

sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna a
0000 000000000
Leuven, Belgium
00 As of 0000
000.00
00.00 0000-00-00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ViAqua Therapeutics Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
0000000 Venture Capital-Backed Leuven, Belgium 00 000.00 0000000000 0 000.00
You’re viewing 1 of 1 competitors. Get the full list »

ViAqua Therapeutics Patents

ViAqua Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10973774-B2 Compositions and methods for treating viral infections in shrimps Active 26-Apr-2016 0000000000 00
US-20190175518-A1 Compositions and methods for treating viral infections in shrimps Granted 26-Apr-2016 0000000000

ViAqua Therapeutics Executive Team (3)

Name Title Board Seat Contact Info
Shai Ufaz Ph.D Co-Founder & Chief Executive Officer
Shai Einbinder Ph.D Co-Founder & Director
Dganit Vered Senior Corporate & R&D Management & Chairman
To view ViAqua Therapeutics’s complete executive team members history, request access »

ViAqua Therapeutics Board Members (1)

Name Representing Role Since
Dganit Vered Self Senior Corporate & R&D Management & Chairman 000 0000
To view ViAqua Therapeutics’s complete board members history, request access »

ViAqua Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ViAqua Therapeutics Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Agriline Corporation Minority 000 0000 000000 0
S2G Ventures Venture Capital Minority 000 0000 000000 0
Thai Union Group Corporation Minority 000 0000 000000 0
VisVires New Protein Venture Capital Minority 000 0000 000000 0
Israel Innovation Authority Government Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »